Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 203

    Novartis completely committed to Sandoz, has no split-off plan

    Novartis 'completely committed' to Sandoz, has no split-off plan

    Medical Dialogues Bureau19 Nov 2018 9:40 AM IST
    ZURICH: Swiss drugmaker Novartis is "completely committed" to its $10 billion-per-year Sandoz generics business, a spokesman said on Thursday after a...
    Drug developer Tesaro explores sale

    Drug developer Tesaro explores sale

    Medical Dialogues Bureau19 Nov 2018 9:00 AM IST
    New Delhi: Cancer Drug Developer Tesaro Inc is exploring a sale and is working with financial advisers after receiving takeover interest, Bloomberg...
    Parnax Lab settles case with SEBI, pays over Rs 10 lakh

    Parnax Lab settles case with SEBI, pays over Rs 10 lakh

    Medical Dialogues Bureau18 Nov 2018 11:45 AM IST
    New Delhi: Pharmaceutical company Parnax Lab has settled proceedings with markets regulator SEBI in connection with alleged violation of listing norms...
    Novartis blood disorder drug Promacta  gets FDA approval

    Novartis blood disorder drug Promacta gets FDA approval

    Medical Dialogues Bureau18 Nov 2018 11:00 AM IST
    Promacta has been approved in more than 90 countries as a treatment for low platelet count in patients with chronic immune thrombocytopenic...
    Shilpa Medicare gets tentative USFDA nod for Multiple Sclerosis drug

    Shilpa Medicare gets tentative USFDA nod for Multiple Sclerosis drug

    Medical Dialogues Bureau18 Nov 2018 10:15 AM IST
    New Delhi: Shilpa Medicare has recently received tentative approval from the US health regulator for Dimethyl Fumarate delayed-release release...
    Eli Lilly considers sale of off-patent drug assets in China

    Eli Lilly considers sale of off-patent drug assets in China

    Medical Dialogues Bureau18 Nov 2018 9:45 AM IST
    New Delhi: Eli Lilly and Co are considering the sale of an off-patent drugs portfolio in China, Bloomberg reported on Friday, citing sources.The...
    Pfizer Q2 net profit falls 14% to Rs 95.8 crore

    Pfizer Q2 net profit falls 14% to Rs 95.8 crore

    Medical Dialogues Bureau18 Nov 2018 9:00 AM IST
    New Delhi: Drug firm Pfizer has recently reported a 13.81 per cent dip in standalone net profit to Rs 95.8 crore for the quarter ended September...
    Zydus Cadila gets USFDA nod to market generic HIV treatment tablets

    Zydus Cadila gets USFDA nod to market generic HIV treatment tablets

    Medical Dialogues Bureau17 Nov 2018 11:45 AM IST
    Ahmedabad: Zydus Cadila has recently received the final approval from the USFDA to market Abacavir and Lamivudine Tablets USP, 600 mg/300 mg, and...
    Merck Foundation announces winners for Merck Diabetes Award 2018

    Merck Foundation announces winners for Merck Diabetes Award 2018

    Medical Dialogues Bureau17 Nov 2018 11:20 AM IST
    Merck Foundation marked the “World Diabetes Day” themed ‘The Family and Diabetes’ on 14th November 2018. Merck Foundation to provide One Year on-line...
    Glenmark gets USFDA nod for Teriflunomide Tablets

    Glenmark gets USFDA nod for Teriflunomide Tablets

    Medical Dialogues Bureau17 Nov 2018 11:00 AM IST
    Mumbai: Glenmark Pharmaceuticals Inc., USA has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for...
    Bayer CropScience Q2 net profit down 25.13 percent

    Bayer CropScience Q2 net profit down 25.13 percent

    Medical Dialogues Bureau17 Nov 2018 10:15 AM IST
    New Delhi: Agro-chemical firm Bayer CropScience has recently posted 25.13 per cent drop in its net profit at Rs 142.7 crore in the second quarter of...
    Arena Pharma soars on deal with United Therapeutics for hypertension drug

    Arena Pharma soars on deal with United Therapeutics for hypertension drug

    Medical Dialogues Bureau17 Nov 2018 9:00 AM IST
    In addition to the upfront payment, Arena's deal with United Therapeutics for its pulmonary arterial hypertension treatment (PAH), ralinepag, will...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Top Pharmacy Courses That Rule the Industry

    Top Pharmacy Courses That Rule the Industry

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok